[144] LIVEPERSON INC SEC Filing
LivePerson, Inc. (LPSN) filing a Form 144 reports a proposed sale of common stock following restricted stock vesting. The notice shows 446,601 shares to be sold through Fidelity Brokerage Services with an aggregate market value of $280,956.69 and an approximate sale date of 09/25/2025 on NASDAQ. The shares were acquired on 09/23/2025 via restricted stock vesting and were paid as compensation. The filer also disclosed a prior sale on 07/28/2025 of 21,966 shares for gross proceeds of $22,526.13. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
- Disclosure compliance is met with required details: acquisition date, nature (restricted stock vesting), broker, sale date, and aggregate market value
- Includes prior recent sale (21,966 shares on 07/28/2025 for $22,526.13), providing transparency about recent dispositions
- Proposed sale size of 446,601 shares is disclosed (aggregate market value $280,956.69), representing a planned insider disposition
- Short notice between vesting and proposed sale: shares acquired 09/23/2025 with approximate sale date 09/25/2025
Insights
TL;DR: Insider plans to sell 446,601 vested shares valued at $280,957 through Fidelity on NASDAQ.
The Form 144 documents a proposed sale of 446,601 common shares acquired by restricted stock vesting on 09/23/2025, with an aggregate market value of $280,956.69 and an approximate sale date of 09/25/2025. The transaction is routed through Fidelity Brokerage Services. The filing also discloses a recent sale of 21,966 shares on 07/28/2025 for $22,526.13. From a trading disclosure perspective, the filing meets Rule 144 notice requirements by identifying acquisition dates, nature of acquisition, and method of payment (compensation).
TL;DR: Form 144 provides required insider-sale disclosure and includes the seller's representation about material information.
The notice specifies the relationship to the issuer via restricted stock vesting and includes the statutory signature attestation regarding absence of undisclosed material adverse information. It identifies the broker, intended exchange (NASDAQ), and prior sales in the three-month window. This filing documents compliance with disclosure obligations tied to insider equity compensation vesting and planned disposition.